128 related articles for article (PubMed ID: 38368952)
1. Association between dermatology follow-up and melanoma survival: A population-based cohort study.
Huang Y; Fleming P; Fung K; Chan AW
J Am Acad Dermatol; 2024 Jun; 90(6):1161-1169. PubMed ID: 38368952
[TBL] [Abstract][Full Text] [Related]
2. Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study.
Chan AW; Fung K; Austin PC; Kim SJ; Singer LG; Baxter NN; Alhusayen R; Rochon PA
Am J Transplant; 2019 Feb; 19(2):522-531. PubMed ID: 29900669
[TBL] [Abstract][Full Text] [Related]
3. Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?
Pitre LD; Linford G; Pond GR; McWhirter E; Seow H
J Cutan Med Surg; 2019; 23(6):586-594. PubMed ID: 31462069
[TBL] [Abstract][Full Text] [Related]
4. The influence of dermatologist and primary care physician visits on melanoma outcomes among Medicare beneficiaries.
Roetzheim RG; Lee JH; Ferrante JM; Gonzalez EC; Chen R; Fisher KJ; Love-Jackson K; McCarthy EP
J Am Board Fam Med; 2013; 26(6):637-47. PubMed ID: 24204060
[TBL] [Abstract][Full Text] [Related]
5. Changing trends in melanoma treatment and the expanding role of the dermatologist.
Brown MD; Johnson TM; Swanson NA
Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
[TBL] [Abstract][Full Text] [Related]
6. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.
McKenna DB; Marioni JC; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Sep; 151(3):636-44. PubMed ID: 15377351
[TBL] [Abstract][Full Text] [Related]
7. Assessment of melanoma follow-up trends in Medicare patients: a large scale, multi-regional analysis.
Hashmi O; Waller JL; Turrentine JE
Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677846
[TBL] [Abstract][Full Text] [Related]
8. Personal history of keratinocyte carcinoma is associated with reduced risk of death from invasive melanoma in men.
Song F; Chen ST; Li X; Han J
J Am Acad Dermatol; 2018 May; 78(5):957-963. PubMed ID: 29317282
[TBL] [Abstract][Full Text] [Related]
9. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
11. Predictors of mucosal melanoma survival in a population-based setting.
Altieri L; Eguchi M; Peng DH; Cockburn M
J Am Acad Dermatol; 2019 Jul; 81(1):136-142.e2. PubMed ID: 30296542
[TBL] [Abstract][Full Text] [Related]
12. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist.
Pennie ML; Soon SL; Risser JB; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2007 Apr; 143(4):488-94. PubMed ID: 17438181
[TBL] [Abstract][Full Text] [Related]
13. Teledermatology for diagnosing skin cancer in adults.
Chuchu N; Dinnes J; Takwoingi Y; Matin RN; Bayliss SE; Davenport C; Moreau JF; Bassett O; Godfrey K; O'Sullivan C; Walter FM; Motley R; Deeks JJ; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013193. PubMed ID: 30521686
[TBL] [Abstract][Full Text] [Related]
14. Management of Melanoma Patients by Non-Dermatologists in the Military Health System: A Retrospective Observational Study.
Helmandollar KJ; Lorei NC; Clement BC; Hoverson KR; Logemann NF
Mil Med; 2020 Mar; 185(3-4):506-511. PubMed ID: 31665406
[TBL] [Abstract][Full Text] [Related]
15. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
16. Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.
Park CK; Dahlke EJ; Fung K; Kitchen J; Austin PC; Rochon PA; Chan AW
J Am Acad Dermatol; 2020 Sep; 83(3):754-761. PubMed ID: 32111554
[TBL] [Abstract][Full Text] [Related]
17. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
18. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
19. Is the survival rate for acral melanoma actually worse than other cutaneous melanomas?
Lim Y; Lee J; Lee DY
J Dermatol; 2020 Mar; 47(3):251-256. PubMed ID: 31889335
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]